氟西汀咀嚼片联合行为管理对犬分离焦虑症的影响。

Effects of reconcile (fluoxetine) chewable tablets plus behavior management for canine separation anxiety.

作者信息

Simpson Barbara Sherman, Landsberg Gary M, Reisner Ilana R, Ciribassi John J, Horwitz Debra, Houpt Katherine A, Kroll Tracy L, Luescher Andrew, Moffat Kelly S, Douglass Genefer, Robertson-Plouch Carol, Veenhuizen Melissa F, Zimmerman Alan, Clark Terrence P

机构信息

Veterinary Behavior Clinic, Southern Pines, NC 28387, USA.

出版信息

Vet Ther. 2007 Spring;8(1):18-31.

PMID:17447222

Abstract

Canine separation anxiety is a common behavioral problem presented to veterinarians. Associated behaviors are distressing to both dog and owner, have the potential to disrupt the human-companion animal bond, and may lead to euthanasia. The results of this study demonstrate the clinical efficacy and safety of Reconcile (fluoxetine, 1 to 2 mg/kg/day [0.45 to 0.91 mg/lb/day]), in conjunction with behavior management, for the treatment of canine separation anxiety. The beef flavored chewable formulation was palatable to treated dogs and easy to administer. This study provides to veterinarians and owners valuable information about an effective separation anxiety treatment plan that combines use of Reconcile with behavior modification.

摘要

犬分离焦虑症是兽医临床上常见的行为问题。相关行为对犬和主人来说都很痛苦，有可能破坏人与伴侣动物之间的关系，甚至可能导致犬被安乐死。本研究结果表明，瑞可妥（氟西汀，1至2毫克/千克/天[0.45至0.91毫克/磅/天]）联合行为管理，在治疗犬分离焦虑症方面具有临床疗效和安全性。牛肉味咀嚼片剂型对接受治疗的犬来说口感良好且易于给药。本研究为兽医和犬主人提供了有价值的信息，即一种将瑞可妥与行为矫正相结合的有效分离焦虑症治疗方案。